{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,25]],"date-time":"2026-07-25T02:59:25Z","timestamp":1784948365007,"version":"3.55.0"},"reference-count":54,"publisher":"Springer Science and Business Media LLC","issue":"4","license":[{"start":{"date-parts":[[2020,8,14]],"date-time":"2020-08-14T00:00:00Z","timestamp":1597363200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2020,8,14]],"date-time":"2020-08-14T00:00:00Z","timestamp":1597363200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"}],"funder":[{"DOI":"10.13039\/100000025","name":"National Institute of Mental Health","doi-asserted-by":"crossref","award":["5UO1MH096754"],"award-info":[{"award-number":["5UO1MH096754"]}],"id":[{"id":"10.13039\/100000025","id-type":"DOI","asserted-by":"crossref"}]},{"DOI":"10.13039\/100000025","name":"National Institute of Mental Health","doi-asserted-by":"crossref","award":["5UO1MH096754"],"award-info":[{"award-number":["5UO1MH096754"]}],"id":[{"id":"10.13039\/100000025","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Soc Psychiatry Psychiatr Epidemiol"],"published-print":{"date-parts":[[2021,4]]},"DOI":"10.1007\/s00127-020-01942-5","type":"journal-article","created":{"date-parts":[[2020,8,14]],"date-time":"2020-08-14T05:02:38Z","timestamp":1597381358000},"page":"695-706","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":17,"title":["Prevalence and clinical correlates of substance use disorders in South African Xhosa patients with schizophrenia"],"prefix":"10.1007","volume":"56","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-7688-0759","authenticated-orcid":false,"given":"Henk","family":"Temmingh","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ezra","family":"Susser","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sumaya","family":"Mall","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Megan","family":"Campbell","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Goodman","family":"Sibeko","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dan J.","family":"Stein","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2020,8,14]]},"reference":[{"issue":"2","key":"1942_CR1","doi-asserted-by":"publisher","first-page":"141","DOI":"10.1111\/j.1600-0447.2005.00554.x","volume":"112","author":"M Lambert","year":"2005","unstructured":"Lambert M, Conus P, Lubman DI, Wade D, Yuen H, Moritz S, Naber D, McGorry PD, Schimmelmann BG (2005) The impact of substance use disorders on clinical outcome in 643 patients with first-episode psychosis. Acta Psychiatr Scand 112(2):141\u2013148. https:\/\/doi.org\/10.1111\/j.1600-0447.2005.00554.x","journal-title":"Acta Psychiatr Scand"},{"issue":"5","key":"1942_CR2","doi-asserted-by":"publisher","first-page":"767","DOI":"10.4088\/JCP.v68n0517","volume":"68","author":"D Wade","year":"2007","unstructured":"Wade D, Harrigan S, McGorry PD, Burgess PM, Whelan G (2007) Impact of severity of substance use disorder on symptomatic and functional outcome in young individuals with first-episode psychosis. J Clin Psychiatry 68(5):767\u2013774","journal-title":"J Clin Psychiatry"},{"issue":"1","key":"1942_CR3","doi-asserted-by":"publisher","first-page":"69","DOI":"10.1016\/S0920-9964(00)00114-6","volume":"48","author":"E Cantor-Graae","year":"2001","unstructured":"Cantor-Graae E, Nordstrom LG, McNeil TF (2001) Substance abuse in schizophrenia: a review of the literature and a study of correlates in Sweden. Schizophr Res 48(1):69\u201382","journal-title":"Schizophr Res"},{"issue":"2","key":"1942_CR4","doi-asserted-by":"publisher","first-page":"85","DOI":"10.1111\/j.1600-0447.2009.01385.x","volume":"120","author":"J Koskinen","year":"2009","unstructured":"Koskinen J, Lohonen J, Koponen H, Isohanni M, Miettunen J (2009) Prevalence of alcohol use disorders in schizophrenia\u2014a systematic review and meta-analysis. Acta Psychiatr Scand 120(2):85\u201396. https:\/\/doi.org\/10.1111\/j.1600-0447.2009.01385.x","journal-title":"Acta Psychiatr Scand"},{"issue":"6","key":"1942_CR5","doi-asserted-by":"publisher","first-page":"1115","DOI":"10.1093\/schbul\/sbp031","volume":"36","author":"J Koskinen","year":"2010","unstructured":"Koskinen J, Lohonen J, Koponen H, Isohanni M, Miettunen J (2010) Rate of cannabis use disorders in clinical samples of patients with schizophrenia: a meta-analysis. Schizophr Bull 36(6):1115\u20131130. https:\/\/doi.org\/10.1093\/schbul\/sbp031","journal-title":"Schizophr Bull"},{"issue":"2","key":"1942_CR6","doi-asserted-by":"publisher","first-page":"106","DOI":"10.1177\/0004867414561526","volume":"49","author":"GE Sara","year":"2015","unstructured":"Sara GE, Large MM, Matheson SL, Burgess PM, Malhi GS, Whiteford HA, Hall WD (2015) Stimulant use disorders in people with psychosis: a meta-analysis of rate and factors affecting variation. Aust N Zeal J Psychiatry 49(2):106\u2013117. https:\/\/doi.org\/10.1177\/0004867414561526","journal-title":"Aust N Zeal J Psychiatry"},{"issue":"1","key":"1942_CR7","doi-asserted-by":"publisher","first-page":"62","DOI":"10.1080\/00207411.2019.1581047","volume":"48","author":"G Ayano","year":"2019","unstructured":"Ayano G (2019) Co-occurring medical and substance use disorders in patients with schizophrenia: a systematic review. Int J Ment Health 48(1):62\u201376. https:\/\/doi.org\/10.1080\/00207411.2019.1581047","journal-title":"Int J Ment Health"},{"key":"1942_CR8","doi-asserted-by":"publisher","first-page":"234","DOI":"10.1016\/j.drugalcdep.2018.07.011","volume":"191","author":"GE Hunt","year":"2018","unstructured":"Hunt GE, Large MM, Cleary M, Lai HMX, Saunders JB (2018) Prevalence of comorbid substance use in schizophrenia spectrum disorders in community and clinical settings, 1990\u20132017: systematic review and meta-analysis. Drug Alcohol Depend 191:234\u2013258. https:\/\/doi.org\/10.1016\/j.drugalcdep.2018.07.011","journal-title":"Drug Alcohol Depend"},{"issue":"1","key":"1942_CR9","doi-asserted-by":"publisher","first-page":"65","DOI":"10.1016\/S0165-1781(01)00250-5","volume":"102","author":"A Gut-Fayand","year":"2001","unstructured":"Gut-Fayand A, Dervaux A, Olie JP, Loo H, Poirier MF, Krebs MO (2001) Substance abuse and suicidality in schizophrenia: a common risk factor linked to impulsivity. Psychiatry Res 102(1):65\u201372","journal-title":"Psychiatry Res"},{"issue":"6","key":"1942_CR10","doi-asserted-by":"publisher","first-page":"452","DOI":"10.1034\/j.1600-0447.2000.101006452.x","volume":"101","author":"M Kamali","year":"2000","unstructured":"Kamali M, Kelly L, Gervin M, Browne S, Larkin C, O'Callaghan E (2000) The prevalence of comorbid substance misuse and its influence on suicidal ideation among in-patients with schizophrenia. Acta Psychiatr Scand 101(6):452\u2013456","journal-title":"Acta Psychiatr Scand"},{"issue":"3","key":"1942_CR11","first-page":"247","volume":"44","author":"BJ Cuffel","year":"1993","unstructured":"Cuffel BJ, Heithoff KA, Lawson W (1993) Correlates of patterns of substance abuse among patients with schizophrenia. Hosp Community Psychiatry 44(3):247\u2013251","journal-title":"Hosp Community Psychiatry"},{"issue":"1\u20133","key":"1942_CR12","doi-asserted-by":"publisher","first-page":"87","DOI":"10.1016\/j.schres.2010.02.1053","volume":"120","author":"L Jimenez-Castro","year":"2010","unstructured":"Jimenez-Castro L, Hare E, Medina R, Raventos H, Nicolini H, Mendoza R, Ontiveros A, Jerez A, Munoz R, Dassori A, Escamilla M (2010) Substance use disorder comorbidity with schizophrenia in families of Mexican and Central American ancestry. Schizophr Res 120(1\u20133):87\u201394. https:\/\/doi.org\/10.1016\/j.schres.2010.02.1053","journal-title":"Schizophr Res"},{"issue":"2\u20133","key":"1942_CR13","doi-asserted-by":"publisher","first-page":"177","DOI":"10.1016\/j.schres.2011.07.032","volume":"132","author":"KE Kerfoot","year":"2011","unstructured":"Kerfoot KE, Rosenheck RA, Petrakis IL, Swartz MS, Keefe RS, McEvoy JP, Stroup TS (2011) Substance use and schizophrenia: adverse correlates in the CATIE study sample. Schizophr Res 132(2\u20133):177\u2013182. https:\/\/doi.org\/10.1016\/j.schres.2011.07.032","journal-title":"Schizophr Res"},{"issue":"2\u20133","key":"1942_CR14","doi-asserted-by":"publisher","first-page":"157","DOI":"10.1016\/s0920-9964(02)00523-6","volume":"67","author":"HC Margolese","year":"2004","unstructured":"Margolese HC, Malchy L, Negrete JC, Tempier R, Gill K (2004) Drug and alcohol use among patients with schizophrenia and related psychoses: levels and consequences. Schizophr Res 67(2\u20133):157\u2013166. https:\/\/doi.org\/10.1016\/s0920-9964(02)00523-6","journal-title":"Schizophr Res"},{"issue":"12","key":"1942_CR15","doi-asserted-by":"publisher","first-page":"810","DOI":"10.1177\/070674370805301207","volume":"53","author":"B Rush","year":"2008","unstructured":"Rush B, Koegl CJ (2008) Prevalence and profile of people with co-occurring mental and substance use disorders within a comprehensive mental health system. Can J Psychiatry 53(12):810\u2013821. https:\/\/doi.org\/10.1177\/070674370805301207","journal-title":"Can J Psychiatry"},{"issue":"1","key":"1942_CR16","doi-asserted-by":"publisher","first-page":"89","DOI":"10.1016\/S0920-9964(02)00292-X","volume":"61","author":"RD Goodwin","year":"2003","unstructured":"Goodwin RD, Amador XF, Malaspina D, Yale SA, Goetz RR, Gorman JM (2003) Anxiety and substance use comorbidity among inpatients with schizophrenia. Schizophr Res 61(1):89\u201395","journal-title":"Schizophr Res"},{"issue":"2\u20133","key":"1942_CR17","doi-asserted-by":"publisher","first-page":"167","DOI":"10.1016\/S0920-9964(03)00188-9","volume":"69","author":"G Scheller-Gilkey","year":"2004","unstructured":"Scheller-Gilkey G, Moynes K, Cooper I, Kant C, Miller AH (2004) Early life stress and PTSD symptoms in patients with comorbid schizophrenia and substance abuse. Schizophr Res 69(2\u20133):167\u2013174","journal-title":"Schizophr Res"},{"issue":"4","key":"1942_CR18","first-page":"219","volume":"10","author":"F Seedat","year":"2007","unstructured":"Seedat F, Roos JL, Pretorius HW, Karayiorgou M, Nel B (2007) Prevalence and clinical characteristics of obsessive-compulsive disorder and obsessive compulsive symptoms in Afrikaner schizophrenia and schizoaffective disorder patients. Afr J Psychiatry (Johannesbg) 10(4):219\u2013224","journal-title":"Afr J Psychiatry (Johannesbg)"},{"issue":"1","key":"1942_CR19","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.comppsych.2006.05.002","volume":"48","author":"G Shoval","year":"2007","unstructured":"Shoval G, Zalsman G, Apter A, Diller R, Sher L, Weizman A (2007) A 10-year retrospective study of inpatient adolescents with schizophrenia\/schizoaffective disorder and substance use. Compr Psychiatry 48(1):1\u20137. https:\/\/doi.org\/10.1016\/j.comppsych.2006.05.002","journal-title":"Compr Psychiatry"},{"key":"1942_CR20","doi-asserted-by":"publisher","first-page":"152","DOI":"10.1016\/j.comppsych.2014.11.021","volume":"58","author":"G Carra","year":"2015","unstructured":"Carra G, Crocamo C, Borrelli P, Popa I, Ornaghi A, Montomoli C, Clerici M (2015) Correlates of dependence and treatment for substance use among people with comorbid severe mental and substance use disorders: findings from the \u201cPsychiatric and Addictive Dual Disorder in Italy (PADDI)\u201d Study. Compr Psychiatry 58:152\u2013159. https:\/\/doi.org\/10.1016\/j.comppsych.2014.11.021","journal-title":"Compr Psychiatry"},{"issue":"6","key":"1942_CR21","doi-asserted-by":"publisher","first-page":"563","DOI":"10.1111\/j.1521-0391.2011.00184.x","volume":"20","author":"MT Compton","year":"2011","unstructured":"Compton MT, Simmons CM, Weiss PS, West JC (2011) Axis IV psychosocial problems among patients with psychotic or mood disorders with a cannabis use disorder comorbidity. Am J Addict 20(6):563\u2013567. https:\/\/doi.org\/10.1111\/j.1521-0391.2011.00184.x","journal-title":"Am J Addict"},{"issue":"12","key":"1942_CR22","doi-asserted-by":"publisher","first-page":"939","DOI":"10.1007\/s00127-005-0964-4","volume":"40","author":"MT Compton","year":"2005","unstructured":"Compton MT, Weiss PS, West JC, Kaslow NJ (2005) The associations between substance use disorders, schizophrenia-spectrum disorders, and Axis IV psychosocial problems. Soc Psychiatry Psychiatr Epidemiol 40(12):939\u2013946. https:\/\/doi.org\/10.1007\/s00127-005-0964-4","journal-title":"Soc Psychiatry Psychiatr Epidemiol"},{"issue":"1","key":"1942_CR23","doi-asserted-by":"publisher","first-page":"72","DOI":"10.1080\/08039480802450439","volume":"63","author":"V Helseth","year":"2009","unstructured":"Helseth V, Lykke-Enger T, Johnsen J, Waal H (2009) Substance use disorders among psychotic patients admitted to inpatient psychiatric care. Nord J Psychiatry 63(1):72\u201377. https:\/\/doi.org\/10.1080\/08039480802450439","journal-title":"Nord J Psychiatry"},{"issue":"1","key":"1942_CR24","doi-asserted-by":"publisher","first-page":"61","DOI":"10.2989\/17280583.2013.767264","volume":"25","author":"S Paruk","year":"2013","unstructured":"Paruk S, Burns JK, Caplan R (2013) Cannabis use and family history in adolescent first episode psychosis in Durban, South Africa. J Child Adolesc Ment Health 25(1):61\u201368. https:\/\/doi.org\/10.2989\/17280583.2013.767264","journal-title":"J Child Adolesc Ment Health"},{"issue":"1","key":"1942_CR25","doi-asserted-by":"publisher","first-page":"51","DOI":"10.2989\/17280583.2017.1318395","volume":"29","author":"B Taukoor","year":"2017","unstructured":"Taukoor B, Paruk S, Karim E, Burns JK (2017) Substance use in adolescents with mental illness in Durban, South Africa. J Child Adolesc Ment Health 29(1):51\u201361. https:\/\/doi.org\/10.2989\/17280583.2017.1318395","journal-title":"J Child Adolesc Ment Health"},{"issue":"5","key":"1942_CR26","first-page":"390","volume":"13","author":"PJ Vos","year":"2010","unstructured":"Vos PJ, Cloete KJ, le Roux A, Kidd M, Jordaan GP (2010) A retrospective review of trends and clinical characteristics of methamphetamine-related acute psychiatric admissions in a South African context. Afr J Psychiatry 13(5):390\u2013394","journal-title":"Afr J Psychiatry"},{"issue":"3","key":"1942_CR27","doi-asserted-by":"publisher","first-page":"213","DOI":"10.4314\/ajpsy.v12i3.48496","volume":"12","author":"L Weich","year":"2009","unstructured":"Weich L, Pienaar W (2009) Occurrence of comorbid substance use disorders among acute psychiatric inpatients at Stikland Hospital in the Western Cape, South Africa. Afr J Psychiatry 12(3):213\u2013217","journal-title":"Afr J Psychiatry"},{"key":"1942_CR28","unstructured":"First M, RL S, M G, JBW W (1994) Structured clinical interview for DSM-IV Axis I disorders-Patient Edition (SCID-I-P, version 2)"},{"key":"1942_CR29","unstructured":"https:\/\/www.scid4.org Structured Clinical Interview for DSM-IV. Biometrics Research Department. Accessed 15 Jan 2018"},{"issue":"11","key":"1942_CR30","doi-asserted-by":"publisher","first-page":"e0188466","DOI":"10.1371\/journal.pone.0188466","volume":"12","author":"MM Campbell","year":"2017","unstructured":"Campbell MM, Susser E, Mall S, Mqulwana SG, Mndini MM, Ntola OA, Nagdee M, Zingela Z, Van Wyk S, Stein DJ (2017) Using iterative learning to improve understanding during the informed consent process in a South African psychiatric genomics study. PLoS ONE 12(11):e0188466. https:\/\/doi.org\/10.1371\/journal.pone.0188466","journal-title":"PLoS ONE"},{"key":"1942_CR31","doi-asserted-by":"publisher","DOI":"10.1017\/s0033291719001703","author":"S Mall","year":"2019","unstructured":"Mall S, Platt JM, Temmingh H, Musenge E, Campbell M, Susser E, Stein DJ (2019) The relationship between childhood trauma and schizophrenia in the Genomics of Schizophrenia in the Xhosa people (SAX) study in South Africa. Psychol Med. https:\/\/doi.org\/10.1017\/s0033291719001703","journal-title":"Psychol Med"},{"issue":"3 Pt 1","key":"1942_CR32","doi-asserted-by":"publisher","first-page":"165","DOI":"10.7196\/samj.5326","volume":"102","author":"L Koen","year":"2012","unstructured":"Koen L, Niehaus DJ, Wright G, Warnich L, De Jong G, Emsley RA, Mall S (2012) Chromosome 22q11 in a Xhosa schizophrenia population. S Afr Med J 102(3 Pt 1):165\u2013166. https:\/\/doi.org\/10.7196\/samj.5326","journal-title":"S Afr Med J"},{"key":"1942_CR33","unstructured":"South African Institute of Race Relations. South African Survey Online (2003) www.irr.org.za. Accessed 15 Jan 2014"},{"issue":"6","key":"1942_CR34","doi-asserted-by":"publisher","first-page":"766","DOI":"10.1001\/archpsyc.1976.01770060086012","volume":"33","author":"J Endicott","year":"1976","unstructured":"Endicott J, Spitzer RL, Fleiss JL, Cohen J (1976) The global assessment scale. A procedure for measuring overall severity of psychiatric disturbance. Arch Gen Psychiatry 33(6):766\u2013771","journal-title":"Arch Gen Psychiatry"},{"issue":"2","key":"1942_CR35","doi-asserted-by":"publisher","first-page":"55","DOI":"10.1007\/BF00801901","volume":"31","author":"N Sartorius","year":"1996","unstructured":"Sartorius N, Janca A (1996) Psychiatric assessment instruments developed by the World Health Organization. Soc Psychiatry Psychiatr Epidemiol 31(2):55\u201369","journal-title":"Soc Psychiatry Psychiatr Epidemiol"},{"issue":"8","key":"1942_CR36","doi-asserted-by":"publisher","first-page":"966","DOI":"10.1001\/archpsyc.64.8.966","volume":"64","author":"DV Jeste","year":"2007","unstructured":"Jeste DV, Palmer BW, Appelbaum PS, Golshan S, Glorioso D, Dunn LB, Kim K, Meeks T, Kraemer HC (2007) A new brief instrument for assessing decisional capacity for clinical research. Arch Gen Psychiatry 64(8):966\u2013974. https:\/\/doi.org\/10.1001\/archpsyc.64.8.966","journal-title":"Arch Gen Psychiatry"},{"key":"1942_CR37","doi-asserted-by":"publisher","DOI":"10.1002\/9780470316696","volume-title":"Multiple imputation for nonresponse in surveys","author":"D Rubin","year":"1987","unstructured":"Rubin D (1987) Multiple imputation for nonresponse in surveys. Wiley, New York"},{"key":"1942_CR38","volume-title":"Stata statistical software: release 13","author":"StataCorp","year":"2013","unstructured":"StataCorp (2013) Stata statistical software: release 13. StataCorp LP, College Station"},{"key":"1942_CR39","doi-asserted-by":"publisher","first-page":"1372","DOI":"10.4102\/sajpsychiatry.v25i0.1372","volume":"25","author":"Y Thungana","year":"2019","unstructured":"Thungana Y, Zingela Z, van Wyk S (2019) First-episode psychosis and substance use in Nelson Mandela Bay: findings from an acute mental health unit. S Afr J Psychiatry 25:1372. https:\/\/doi.org\/10.4102\/sajpsychiatry.v25i0.1372","journal-title":"S Afr J Psychiatry"},{"issue":"5 Pt 2","key":"1942_CR40","first-page":"339","volume":"99","author":"AA Herman","year":"2009","unstructured":"Herman AA, Stein DJ, Seedat S, Heeringa SG, Moomal H, Williams DR (2009) The South African Stress and Health (SASH) study: 12-month and lifetime prevalence of common mental disorders. S Afr Med J 99(5 Pt 2):339\u2013344","journal-title":"S Afr Med J"},{"issue":"4","key":"1942_CR41","doi-asserted-by":"publisher","first-page":"494","DOI":"10.1016\/j.cpr.2006.09.004","volume":"27","author":"L Gregg","year":"2007","unstructured":"Gregg L, Barrowclough C, Haddock G (2007) Reasons for increased substance use in psychosis. Clin Psychol Rev 27(4):494\u2013510. https:\/\/doi.org\/10.1016\/j.cpr.2006.09.004","journal-title":"Clin Psychol Rev"},{"issue":"7","key":"1942_CR42","doi-asserted-by":"publisher","first-page":"549","DOI":"10.1016\/j.biopsych.2015.08.001","volume":"79","author":"SH Gage","year":"2016","unstructured":"Gage SH, Hickman M, Zammit S (2016) Association between cannabis and psychosis: epidemiologic evidence. Biol Psychiat 79(7):549\u2013556. https:\/\/doi.org\/10.1016\/j.biopsych.2015.08.001","journal-title":"Biol Psychiat"},{"issue":"1\u20132","key":"1942_CR43","doi-asserted-by":"publisher","first-page":"70","DOI":"10.1016\/j.psychres.2015.07.070","volume":"229","author":"A Man\u00e9","year":"2015","unstructured":"Man\u00e9 A, Fern\u00e1ndez-Exp\u00f3sito M, Berg\u00e9 D, G\u00f3mez-P\u00e9rez L, Sabat\u00e9 A, Toll A, Diaz L, Diez-Aja C, Perez V (2015) Relationship between cannabis and psychosis: reasons for use and associated clinical variables. Psychiatry Res 229(1\u20132):70\u201374. https:\/\/doi.org\/10.1016\/j.psychres.2015.07.070","journal-title":"Psychiatry Res"},{"issue":"11","key":"1942_CR44","doi-asserted-by":"publisher","first-page":"1036","DOI":"10.1177\/0004867414533838","volume":"48","author":"GE Sara","year":"2014","unstructured":"Sara GE, Burgess PM, Malhi GS, Whiteford HA, Hall WC (2014) Stimulant and other substance use disorders in schizophrenia: prevalence, correlates and impacts in a population sample. Aust N Zeal J Psychiatry 48(11):1036\u20131047. https:\/\/doi.org\/10.1177\/0004867414533838","journal-title":"Aust N Zeal J Psychiatry"},{"issue":"3","key":"1942_CR45","doi-asserted-by":"publisher","first-page":"164","DOI":"10.1097\/01.nmd.0000202575.79453.6e","volume":"194","author":"MS Swartz","year":"2006","unstructured":"Swartz MS, Wagner HR, Swanson JW, Stroup TS, McEvoy JP, Canive JM, Miller DD, Reimherr F, McGee M, Khan A, Van Dorn R, Rosenheck RA, Lieberman JA (2006) Substance use in persons with schizophrenia: baseline prevalence and correlates from the NIMH CATIE study. J Nerv Ment Dis 194(3):164\u2013172. https:\/\/doi.org\/10.1097\/01.nmd.0000202575.79453.6e","journal-title":"J Nerv Ment Dis"},{"issue":"1","key":"1942_CR46","first-page":"45","volume":"16","author":"A Pluddemann","year":"2013","unstructured":"Pluddemann A, Dada S, Parry CD, Kader R, Parker JS, Temmingh H, van Heerden S, de Clercq C, Lewis I (2013) Monitoring the prevalence of methamphetamine-related presentations at psychiatric hospitals in Cape Town, South Africa. Afr J Psychiatry (Johannesbg) 16(1):45\u201349","journal-title":"Afr J Psychiatry (Johannesbg)"},{"key":"1942_CR47","doi-asserted-by":"publisher","first-page":"99","DOI":"10.1016\/j.drugpo.2015.10.006","volume":"30","author":"AL Hobkirk","year":"2016","unstructured":"Hobkirk AL, Watt MH, Myers B, Skinner D, Meade CS (2016) A qualitative study of methamphetamine initiation in Cape Town, South Africa. Int J Drug Pol 30:99\u2013106. https:\/\/doi.org\/10.1016\/j.drugpo.2015.10.006","journal-title":"Int J Drug Pol"},{"issue":"3","key":"1942_CR48","doi-asserted-by":"publisher","first-page":"218","DOI":"10.1097\/yco.0000000000000488","volume":"32","author":"N Morgan","year":"2019","unstructured":"Morgan N, Mall S (2019) Pathways between urbanization and harmful substance use. Curr Opin Psychiatry 32(3):218\u2013223. https:\/\/doi.org\/10.1097\/yco.0000000000000488","journal-title":"Curr Opin Psychiatry"},{"issue":"Suppl 1","key":"1942_CR49","doi-asserted-by":"publisher","first-page":"11","DOI":"10.11694\/pamj.supp.2014.17.1.3328","volume":"17","author":"A Saban","year":"2014","unstructured":"Saban A, Flisher AJ, Grimsrud A, Morojele N, London L, Williams DR, Stein DJ (2014) The association between substance use and common mental disorders in young adults: results from the South African Stress and Health (SASH) Survey. Pan Afr Med J 17(Suppl 1):11. https:\/\/doi.org\/10.11694\/pamj.supp.2014.17.1.3328","journal-title":"Pan Afr Med J"},{"issue":"3","key":"1942_CR50","doi-asserted-by":"publisher","first-page":"375","DOI":"10.1002\/jts.20131","volume":"19","author":"T O'Hare","year":"2006","unstructured":"O'Hare T, Sherrer MV, Shen C (2006) Subjective distress from stressful events and high-risk behaviors as predictors of PTSD symptom severity in clients with severe mental illness. J Trauma Stress 19(3):375\u2013386. https:\/\/doi.org\/10.1002\/jts.20131","journal-title":"J Trauma Stress"},{"issue":"5","key":"1942_CR51","doi-asserted-by":"publisher","first-page":"465","DOI":"10.1016\/j.addbeh.2011.01.006","volume":"36","author":"T O'Hare","year":"2011","unstructured":"O'Hare T, Sherrer M (2011) Drinking motives as mediators between PTSD symptom severity and alcohol consumption in persons with severe mental illnesses. Addict Behav 36(5):465\u2013469. https:\/\/doi.org\/10.1016\/j.addbeh.2011.01.006","journal-title":"Addict Behav"},{"issue":"6","key":"1942_CR52","doi-asserted-by":"publisher","first-page":"e739","DOI":"10.4088\/JCP.16f10918","volume":"77","author":"C Andrade","year":"2016","unstructured":"Andrade C (2016) Cannabis and neuropsychiatry, 2: the longitudinal risk of psychosis as an adverse outcome. J Clin Psychiatry 77(6):e739\u2013742. https:\/\/doi.org\/10.4088\/JCP.16f10918","journal-title":"J Clin Psychiatry"},{"issue":"4 Suppl","key":"1942_CR53","first-page":"S22","volume":"190","author":"DF Hermens","year":"2009","unstructured":"Hermens DF, Lubman DI, Ward PB, Naismith SL, Hickie IB (2009) Amphetamine psychosis: a model for studying the onset and course of psychosis. Med J Aust 190(4 Suppl):S22\u201325","journal-title":"Med J Aust"},{"issue":"14","key":"1942_CR54","doi-asserted-by":"publisher","first-page":"2461","DOI":"10.1017\/s0033291717000976","volume":"47","author":"C Ouellet-Plamondon","year":"2017","unstructured":"Ouellet-Plamondon C, Abdel-Baki A, Salvat E, Potvin S (2017) Specific impact of stimulant, alcohol and cannabis use disorders on first-episode psychosis: 2-year functional and symptomatic outcomes. Psychol Med 47(14):2461\u20132471. https:\/\/doi.org\/10.1017\/s0033291717000976","journal-title":"Psychol Med"}],"container-title":["Social Psychiatry and Psychiatric Epidemiology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00127-020-01942-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00127-020-01942-5\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00127-020-01942-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,8,13]],"date-time":"2021-08-13T23:06:46Z","timestamp":1628896006000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00127-020-01942-5"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,8,14]]},"references-count":54,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2021,4]]}},"alternative-id":["1942"],"URL":"https:\/\/doi.org\/10.1007\/s00127-020-01942-5","relation":{},"ISSN":["0933-7954","1433-9285"],"issn-type":[{"value":"0933-7954","type":"print"},{"value":"1433-9285","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,8,14]]},"assertion":[{"value":"28 October 2019","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"7 August 2020","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"14 August 2020","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"HT, ES, SM, MC, and GS and have not received any financial or commercial related compensation that can be considered to represent a conflict of interest. DJS is supported by the Medical Research Council of South Africa and has received research grants and\/or consultancy honoraria from: Abbott, Astrazeneca, Eli-Lilly, GlaxoSmithKline, Jazz Pharmaceuticals, Johnson & Johnson,\u00a0Lundbeck, Orion, Pfizer, Pharmacia, Roche, Servier, Solvay, Sumitomo, Sun, Takeda, Tikvah, and Wyeth. DJS is also on the scientific advisory board of the TLC Foundation for Body-Focused Repetitive Behaviours, the Anxiety and Depression Association of America (ADAA), and the South African Depression and Anxiety Support Group. SM has received incentive funding for rated researchers from the South African National Research Foundation (NRF) (Grant No. 119375).","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}},{"value":"The Human Ethics Committee of the Faculty of Health Sciences, University of Cape Town, South Africa granted approval to the study (HREC No. 049\/2013). In addition, ethical approval was also obtained from the Walter Sisulu University Research Ethics and Biosafety Committee, The Rhodes University Ethical Standards Committee, The Columbia University Internal Review Board and the University of Washington Institutional Review Board. To ensure that participants understood and had sufficient decisional capacity to understand the nature of the study, the University of California, San Diego Brief Assessment of Capacity to Consent (UBACC) questionnaire [30] was administered to all participants.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval"}}]}}